Sensei Biotherapeutics, Inc. announced unaudited earnings results for the year ended December 31, 2020. Net loss was $20.1 million, for the year ended December 31, 2020, compared to $16.7 million for the year ended December 31, 2019. Loss from operations was $19,451,000 against $12,435,000 a year ago. Net loss per share, basic and diluted was $12.53 against $55.92 a year ago.